MARKET

EARS

EARS

Auris Medical Holding Ltd
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.545
-0.081
-4.96%
After Hours: 1.500 -0.045 -2.91% 18:44 01/17 EST
OPEN
1.580
PREV CLOSE
1.626
HIGH
1.590
LOW
1.510
VOLUME
199.77K
TURNOVER
--
52 WEEK HIGH
10.69
52 WEEK LOW
1.300
MARKET CAP
37.20M
P/E (TTM)
-0.2206
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of EARS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

EARS News

  • Auris Medical nabs new patent in Europe; shares up 12% premarket
  • Seeking Alpha - Article.01/10 13:43
  • Auris Medical Announces Notice of Allowance for European Patent Application
  • GlobeNewswire.01/10 13:30
  • NIO, FCEL among premarket gainers
  • Seeking Alpha - Article.12/30/2019 14:25
  • Auris Medical Announces Formation of New Subsidiary for Development Projects in Tinnitus and Hearing Loss
  • GlobeNewswire.12/30/2019 13:30

More

Industry

Biotechnology & Medical Research
-0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About EARS

Auris Medical Holding AG is a Switzerland-based biotechnology company engaged in developing pharmaceutical products for the treatment of inner ear disorders and mental health supportive care. The Company focuses on the development of intranasal betahistine for the treatment of vertigo (AM-125) and for the treatment of antipsychotic-induced weight gain and somnolence (AM-201). The betahistine program is in Phase 1 of clinical trials. Other programs in the Company's product pipeline include brimapitide-based AM-111 for the treatment of acute inner ear hearing loss and eskatemine-based Keyzilen (AM-101) for the treatment of acute inner ear tinnitus, both in Phase 3 of clinical trials, as well as AM-102 indicated for tinnitus, undergoing preclinical studies focused on selecting the lead compound. The Company operates through subsidiaries in Switzerland, Ireland and the United States.
More

Webull offers Auris Medical Holding Ltd (EARS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.